What are the side effects of amlodipine (calcium channel blocker)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Side Effects of Amlodipine

The most common side effects of amlodipine are peripheral edema (leg/ankle swelling), headache, dizziness, and flushing, with edema being dose-dependent and occurring in up to 10.8% of patients at the 10 mg dose. 1

Most Common Adverse Effects

Peripheral Edema (Most Frequent)

  • Peripheral edema is the most characteristic side effect of amlodipine, occurring in a dose-dependent manner: 1.8% at 2.5 mg, 3.0% at 5 mg, and 10.8% at 10 mg daily 1
  • Women experience significantly higher rates of edema (14.6%) compared to men (5.6%) 1
  • This edema results from the vasodilatory action of the drug and can be managed with diuretics 2
  • In pediatric populations, generalized edema can occur and resolves with discontinuation of the medication 3

Vasodilatory Side Effects

  • Flushing occurs in 0.7% at 2.5 mg, 1.4% at 5 mg, and 2.6% at 10 mg, with women experiencing higher rates (4.5%) than men (1.5%) 1
  • Dizziness affects 1.1% to 3.4% of patients across dosing ranges 1
  • Headache is noted as a common adverse effect related to vasodilation 2, 4
  • Palpitations occur in 0.7% to 4.5% of patients in a dose-dependent manner, more frequently in women (3.3%) than men (1.4%) 1

Other Common Side Effects (>1% Incidence)

  • Fatigue: 4.5% of patients (compared to 2.8% with placebo) 1
  • Nausea: 2.9% of patients 1
  • Abdominal pain: 1.6% of patients 1
  • Somnolence: 1.4% of patients, slightly higher in women 1

Less Common but Clinically Important Side Effects (<1% but >0.1%)

Cardiovascular

  • Arrhythmias (including ventricular tachycardia and atrial fibrillation), bradycardia, chest pain, syncope, tachycardia 1

Neurological

  • Hypoesthesia, peripheral neuropathy, paresthesia, tremor, vertigo 1

Gastrointestinal

  • Constipation, dysphagia, diarrhea, flatulence, pancreatitis, vomiting, gingival hyperplasia 1

Musculoskeletal

  • Muscle cramps, myalgia, arthralgia 1

Dermatologic

  • Angioedema, erythema multiforme, pruritus, various rashes 1

Other Systems

  • Sexual dysfunction, insomnia, nervousness, depression, dyspnea 1

Important Clinical Considerations

Discontinuation Rate

  • Only approximately 1.5% of patients discontinue amlodipine due to adverse reactions, which is not significantly different from placebo 1
  • Amlodipine is generally well tolerated at doses up to 10 mg daily 1, 5

Laboratory Parameters

  • No clinically significant changes occur in serum potassium, glucose, triglycerides, cholesterol, uric acid, blood urea nitrogen, or creatinine 1
  • Unlike some antihypertensive agents, amlodipine does not adversely affect serum lipid or glucose levels 5, 6

Special Populations

  • In pediatric patients, adverse effects include dizziness, fatigue, flushing, and leg edema, all of which improve with dose reduction 7
  • A small, clinically insignificant increase in heart rate may occur in children (from 91 to 99 beats/min) 7

Critical Safety Points

When to Avoid or Use with Caution

  • Do not use if allergic to amlodipine or any inactive ingredients 1
  • In patients with heart failure, amlodipine may precipitate or worsen symptoms, though it was shown safe in the PRAISE trial for nonischemic dilated cardiomyopathy 2
  • Systemic hypotension can occur, potentially causing reflex tachycardia, sympathetic stimulation, and right ventricular ischemia 2

Rare but Serious Effects

  • Gynecomastia has been reported infrequently in postmarketing surveillance 1
  • Hematologic effects including leukopenia, purpura, and thrombocytopenia are rare 1

Drug-Specific Advantages

  • Amlodipine does not cause cardiac conduction disturbances or postural hypotension, unlike some other cardiovascular agents 6
  • No clinically important drug interactions have been observed 5
  • The long half-life (35-50 hours) provides continuous protection even if a dose is missed 8

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Amlodipine: The double edged sword.

Journal of paediatrics and child health, 2017

Guideline

Amlodipine Dosing Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Amlodipine: a new calcium antagonist.

American journal of hospital pharmacy, 1994

Research

Treatment of hypertensive children with amlodipine.

American journal of hypertension, 2000

Research

Amlodipine in the current management of hypertension.

Journal of clinical hypertension (Greenwich, Conn.), 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.